Company Imv Inc Toronto S.E.
Equities
CA45254B1031
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 09/11/20 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | - | |
Stéphane Fiset
CTO | Chief Tech/Sci/R&D Officer | - | - |
Annie Tanguay
CMP | Compliance Officer | - | - |
Jeremy Graff
CTO | Chief Tech/Sci/R&D Officer | - | 13/06/21 |
Delphine Davan
IRC | Investor Relations Contact | - | 31/07/19 |
Linda Barabe
IRO | Public Communications Contact | - | - |
Ryan Marshall
PRN | Corporate Officer/Principal | - | 31/12/15 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 30/06/20 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 31/03/21 |
Markus Warmuth
BRD | Director/Board Member | 53 | 05/11/18 |
Shabnam Kazmi
BRD | Director/Board Member | - | 07/01/23 |
Andrew Hall
CEO | Chief Executive Officer | - | 09/11/20 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Michael Kalos
BRD | Director/Board Member | 62 | 10/05/21 |
Saman Maleki
BRD | Director/Board Member | - | 14/09/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,711,637 | 11,703,501 ( 99.93 %) | 0 | 99.93 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |